NO20110429L - Polypeptider og nukleinsyre-DNA for anvendelse innen medisin - Google Patents
Polypeptider og nukleinsyre-DNA for anvendelse innen medisinInfo
- Publication number
- NO20110429L NO20110429L NO20110429A NO20110429A NO20110429L NO 20110429 L NO20110429 L NO 20110429L NO 20110429 A NO20110429 A NO 20110429A NO 20110429 A NO20110429 A NO 20110429A NO 20110429 L NO20110429 L NO 20110429L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptides
- medicine
- nucleic acid
- acid dna
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20110429A NO342257B1 (no) | 2000-12-22 | 2011-03-21 | Polypeptider, nukleinsyre-DNA og vektorer for anvendelse som et medikament i behandling av cancer |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0031430.2A GB0031430D0 (en) | 2000-12-22 | 2000-12-22 | Polypeptides |
PCT/NO2001/000498 WO2002051994A2 (en) | 2000-12-22 | 2001-12-18 | Polypeptides |
NO20110429A NO342257B1 (no) | 2000-12-22 | 2011-03-21 | Polypeptider, nukleinsyre-DNA og vektorer for anvendelse som et medikament i behandling av cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20110429L true NO20110429L (no) | 2003-08-21 |
NO342257B1 NO342257B1 (no) | 2018-04-30 |
Family
ID=9905720
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20032818A NO332137B1 (no) | 2000-12-22 | 2003-06-19 | Polypeptid, nukleinsyre, T-lymfocytt og vektor for anvendelse innen medisin samt farmasoytisk sammensetning omfattende nevnte polypeptid. |
NO20110429A NO342257B1 (no) | 2000-12-22 | 2011-03-21 | Polypeptider, nukleinsyre-DNA og vektorer for anvendelse som et medikament i behandling av cancer |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20032818A NO332137B1 (no) | 2000-12-22 | 2003-06-19 | Polypeptid, nukleinsyre, T-lymfocytt og vektor for anvendelse innen medisin samt farmasoytisk sammensetning omfattende nevnte polypeptid. |
Country Status (14)
Country | Link |
---|---|
US (4) | US7078416B2 (no) |
EP (3) | EP1862544B2 (no) |
JP (3) | JP2004522433A (no) |
AT (2) | ATE550426T1 (no) |
AU (3) | AU2002216477B2 (no) |
CA (2) | CA2432971C (no) |
CY (2) | CY1106564T1 (no) |
DE (1) | DE60127715T2 (no) |
DK (3) | DK2361978T3 (no) |
ES (2) | ES2382821T3 (no) |
GB (1) | GB0031430D0 (no) |
NO (2) | NO332137B1 (no) |
PT (2) | PT1862544E (no) |
WO (1) | WO2002051994A2 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO315238B1 (no) * | 1998-05-08 | 2003-08-04 | Gemvax As | Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy |
US7388071B2 (en) * | 2000-02-15 | 2008-06-17 | The Regents Of The University Of California | Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response |
GB0031430D0 (en) * | 2000-12-22 | 2001-02-07 | Norsk Hydro As | Polypeptides |
US7439042B2 (en) * | 2002-12-16 | 2008-10-21 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
ES2676503T3 (es) * | 2002-12-16 | 2018-07-20 | Globeimmune, Inc. | Vacunas basadas en levadura como inmunoterapia |
US8343502B2 (en) * | 2002-12-16 | 2013-01-01 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
WO2004111075A2 (en) | 2003-03-05 | 2004-12-23 | Dendreon Corporation | Alternative reading frame polypeptides for treatment |
EP2460533A3 (en) | 2004-10-18 | 2014-01-08 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
US9732131B2 (en) | 2006-02-27 | 2017-08-15 | Calviri, Inc. | Identification and use of novopeptides for the treatment of cancer |
JP2012503011A (ja) | 2008-09-19 | 2012-02-02 | グローブイミューン,インコーポレイテッド | 慢性c型肝炎ウイルス感染の免疫療法 |
GB0821616D0 (en) | 2008-11-26 | 2008-12-31 | Lytix Biopharma As | Compounds |
WO2018145020A1 (en) | 2017-02-03 | 2018-08-09 | The Medical College Of Wisconsin, Inc. | Kras peptide vaccine compositions and method of use |
CA3065325A1 (en) | 2017-06-02 | 2018-12-06 | Arizona Board Of Regents On Behalf Of Arizona State University | A method to create personalized cancer vaccines |
WO2019055618A1 (en) | 2017-09-15 | 2019-03-21 | Arizona Board Of Regents On Behalf Of Arizona State University | METHODS OF CLASSIFYING RESPONSES TO ANTICANCER IMMUNOTHERAPY |
EP4038222A4 (en) | 2019-10-02 | 2023-10-18 | Arizona Board of Regents on behalf of Arizona State University | METHODS AND COMPOSITIONS FOR IDENTIFYING NEOANTIGENS FOR USE IN THE TREATMENT AND PREVENTION OF CANCER |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4803070A (en) | 1986-04-15 | 1989-02-07 | Ribi Immunochem Research Inc. | Immunological emulsion adjuvants for polysaccharide vaccines |
GB9103974D0 (en) | 1991-02-26 | 1991-04-10 | Norsk Hydro As | Therapeutically useful peptides or peptide fragments |
IL133830A0 (en) | 1997-07-01 | 2001-04-30 | Cambia Biosystems Llc | Vertebrate tolomerase genes and proteins and uses thereof |
WO1999050932A1 (fr) * | 1998-03-31 | 1999-10-07 | Matsushita Electric Industrial Co., Ltd. | Antenne et televiseur numerique |
WO1999050392A1 (en) * | 1998-03-31 | 1999-10-07 | Geron Corporation | Methods and compositions for eliciting an immune response to a telomerase antigen |
US6337200B1 (en) * | 1998-03-31 | 2002-01-08 | Geron Corporation | Human telomerase catalytic subunit variants |
NO315238B1 (no) | 1998-05-08 | 2003-08-04 | Gemvax As | Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy |
US7030211B1 (en) * | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
EP1171612A2 (en) * | 1999-04-09 | 2002-01-16 | Biomira, Inc. | Telomerase-specific cancer vaccine |
AU5047800A (en) | 1999-05-28 | 2000-12-18 | Ludwig Institute For Cancer Research | Breast, gastric and prostate cancer associated antigens and uses therefor |
GB0031430D0 (en) * | 2000-12-22 | 2001-02-07 | Norsk Hydro As | Polypeptides |
-
2000
- 2000-12-22 GB GBGB0031430.2A patent/GB0031430D0/en not_active Ceased
-
2001
- 2001-12-18 DK DK10183829.0T patent/DK2361978T3/en active
- 2001-12-18 EP EP07105178.3A patent/EP1862544B2/en not_active Expired - Lifetime
- 2001-12-18 JP JP2002553475A patent/JP2004522433A/ja active Pending
- 2001-12-18 AT AT07105178T patent/ATE550426T1/de active
- 2001-12-18 AT AT01272392T patent/ATE358716T1/de active
- 2001-12-18 DE DE60127715T patent/DE60127715T2/de not_active Expired - Lifetime
- 2001-12-18 CA CA2432971A patent/CA2432971C/en not_active Expired - Fee Related
- 2001-12-18 US US10/451,050 patent/US7078416B2/en not_active Expired - Lifetime
- 2001-12-18 AU AU2002216477A patent/AU2002216477B2/en not_active Ceased
- 2001-12-18 ES ES07105178T patent/ES2382821T3/es not_active Expired - Lifetime
- 2001-12-18 WO PCT/NO2001/000498 patent/WO2002051994A2/en active IP Right Grant
- 2001-12-18 CA CA2782510A patent/CA2782510C/en not_active Expired - Fee Related
- 2001-12-18 ES ES01272392T patent/ES2280311T3/es not_active Expired - Lifetime
- 2001-12-18 EP EP01272392A patent/EP1352056B1/en not_active Expired - Lifetime
- 2001-12-18 PT PT07105178T patent/PT1862544E/pt unknown
- 2001-12-18 EP EP10183829.0A patent/EP2361978B1/en not_active Expired - Lifetime
- 2001-12-18 DK DK07105178.3T patent/DK1862544T3/da active
- 2001-12-18 PT PT01272392T patent/PT1352056E/pt unknown
- 2001-12-18 DK DK01272392T patent/DK1352056T3/da active
-
2003
- 2003-06-19 NO NO20032818A patent/NO332137B1/no not_active IP Right Cessation
-
2006
- 2006-03-29 US US11/391,497 patent/US7375117B2/en not_active Expired - Fee Related
-
2007
- 2007-05-07 CY CY20071100601T patent/CY1106564T1/el unknown
- 2007-08-22 AU AU2007211889A patent/AU2007211889C1/en not_active Ceased
-
2008
- 2008-03-05 US US12/042,837 patent/US8193326B2/en not_active Expired - Fee Related
-
2010
- 2010-02-19 AU AU2010200620A patent/AU2010200620B2/en not_active Ceased
-
2011
- 2011-03-21 NO NO20110429A patent/NO342257B1/no not_active IP Right Cessation
- 2011-10-12 JP JP2011225178A patent/JP2012080883A/ja active Pending
-
2012
- 2012-05-14 CY CY20121100447T patent/CY1112735T1/el unknown
- 2012-05-31 US US13/484,829 patent/US20120269858A1/en not_active Abandoned
-
2014
- 2014-01-16 JP JP2014005980A patent/JP2014138587A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20110429L (no) | Polypeptider og nukleinsyre-DNA for anvendelse innen medisin | |
MX344216B (es) | Productos geneticos expresados de forma diferencial en tumores y su uso. | |
CY1109463T1 (el) | Πεπτιδια kdr και εμβολια που τα περιλαμβανουν | |
HUP0105303A2 (en) | Her-2/neu fusion proteins | |
ATE386800T1 (de) | Immunogene chimäre umfassend nucleinsäuresequenzen, die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten | |
DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
HUP0302532A2 (hu) | Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások | |
ATE418563T1 (de) | Nik proteine, nukleinsäure sowie verfahren | |
DE60035337D1 (de) | Humane Peptide/Proteine, die das Töten von Zellen, einschliesslich lymphoide Tumorzellen, herbeiführen oder bewirken | |
DK0750672T3 (da) | DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse | |
WO2002008277A3 (en) | Nucleic acids, vectors, host cells, polypeptides, and uses thereof | |
ATE521702T1 (de) | Krebsantigene und deren nutzung | |
WO2005026205A3 (de) | Differentiell in tumoren exprimierte genprodukte und deren verwendung | |
HUP0100267A2 (hu) | Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények | |
RS20050577A (en) | Compositions and methods for treating cancer using igsf9 and liv-1 | |
HUP0400703A2 (hu) | Csökkentett immunogenitású módosított eritropoietin (EPO) | |
HUP0302566A2 (hu) | Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására | |
WO2003093298A3 (en) | Immunogenic peptides | |
DE60135232D1 (de) | Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen | |
FR2813606B1 (fr) | Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques | |
ATE315406T1 (de) | Semi-allogene antitumor-vakzine mit hla-haplo- identischen antigen-präsentierenden zellen | |
TW200518770A (en) | Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof | |
WO2004044126A3 (en) | Novel proteins and their uses | |
AR045521A1 (es) | Promotor del gen de fatp5 humano y usos | |
TH55539B (th) | เพปไทด์ที่เป็นแอนติเจน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |